Novavax files COVID-19 vaccine data with FDA

Novavax files data with FDA to support COVID vaccine

The announcement comes shortly after the European Commission and World Health Organization cleared use of the Maryland-based company’s two-dose shot.

Novavax submits the final data packets to the US FDA as a prerequisite for the application for an emergency use authorization application for the COVID-19 vaccine

GAITHERSBURG, Md., Dec. 31, 2021 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing

Novavax files COVID-19 vaccine data with FDA

Novavax on Friday filed final data with the Food and Drug Administration (FDA) for its COVID-19 vaccine, clearing the way for a potential emergency approval next year.

Novavax to submit COVID-19 vaccine EUA request to U.S. FDA next month

Novavax Inc will submit a request to the U.S. Food and Drug Administration to authorize its COVID-19 vaccine next month, further delaying the submission it had expected by the end of this year.

Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency Use Authorization Application Request for COVID-19 Vaccine

GAITHERSBURG, Md., Dec. 31, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing...

Novavax submits data to U.S. FDA for COVID-19 vaccine

Dec 31 - Novavax Inc said on Friday it had Read More